SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Orleans Capital Management Corp LA

Orleans Capital Management Corp LA increased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 30.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,835 shares of the exchange traded fund’s stock after purchasing an additional 3,650 shares during the period. Orleans Capital Management Corp LA’s holdings in SPDR S&P Biotech ETF were worth $1,764,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. Envestnet Asset Management Inc. grew its position in SPDR S&P Biotech ETF by 64.6% in the 3rd quarter. Envestnet Asset Management Inc. now owns 33,852 shares of the exchange traded fund’s stock valued at $3,772,000 after buying an additional 13,287 shares in the last quarter. Private Trust Co. NA raised its holdings in SPDR S&P Biotech ETF by 6.8% during the third quarter. Private Trust Co. NA now owns 2,102 shares of the exchange traded fund’s stock worth $234,000 after purchasing an additional 133 shares in the last quarter. Sawtooth Solutions LLC bought a new stake in SPDR S&P Biotech ETF during the second quarter worth approximately $421,000. Fisher Asset Management LLC acquired a new stake in SPDR S&P Biotech ETF in the second quarter worth approximately $288,000. Finally, Flow Traders U.S. LLC bought a new position in SPDR S&P Biotech ETF during the 2nd quarter valued at $2,415,000.

Shares of XBI traded down $1.03 during midday trading on Monday, reaching $130.43. The stock had a trading volume of 129,000 shares, compared to its average volume of 6,090,407. The firm’s 50 day moving average price is $120.59 and its 200-day moving average price is $112.30. SPDR S&P Biotech ETF has a 52 week low of $62.94 and a 52 week high of $132.32.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: How analysts view the yield curve

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.